New York, New York--(Newsfile Corp. - July 23, 2026) - Kaplan Fox &amp; Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (&#34;Alignment Healthcare&#34; or the

<p>New York, New York--(Newsfile Corp. - July 23, 2026) - <a href="https://api.newsfilecorp.com/redirect/Pq0WwHqzvb">Kaplan Fox &#38; Kilsheimer LLP</a> is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/ALHC">ALHC</a>).</p><p style="text-align: center;"><a href="https://api.newsfilecorp.com/redirect/wEQM1irgzV">CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION</a></p><p><b>If you are an Alignment Healthcare investor and have suffered losses, or if you have information that could assist in the Alignment Healthcare investigation, you may </b><a href="https://api.newsfilecorp.com/redirect/gJgVPHN1rD"><b>CLICK HERE</b></a><b> to contact us. You may also contact Kaplan Fox by emailing </b><a href="mailto:pmayer@kaplanfox.com"><b>pmayer@kaplanfox.com</b></a><b> or by calling (646) 315-9003.</b></p><p>On July 8, 2026, news emerged that a former Alignment Healthcare executive had filed a whistleblower complaint alleging the Company engaged in "accounting irregularities" that "artificially inflated" Alignment Healthcare's previously reported and projected financial results, including "Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization ("Adjusted EBITDA"), a key non-GAAP financial metric central to the Company's reported financial performance and executive compensation structure." According to the lawsuit "millions of dollars in operating expenses had been systematically misclassified as capital expenditures."  </p><p>Following this news, on July 8, 2026, the price of Alignment Healthcare stock fell $4.02 per share, or 16.7%, to close at $20.03 per share.</p><p><b>WHY CONTACT KAPLAN FOX?</b></p><p>Kaplan Fox &#38; Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.</p><p>Kaplan Fox is widely regarded as one of the nation's premier plaintiffs' securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in <i>In re Bank of America</i><span style="font-size: 12pt;">&#8212;</span>the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act<span style="font-size: 12pt;">&#8212;</span>$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in <i>ATRS v. Allianz Global Investors</i>, and a $475 million settlement in <i>In re Merrill Lynch</i>.</p><p>For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.</p><p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Past results do not guarantee future outcomes.</p><p>If you have any questions about this investigation, please contact:</p><div id="contactInfo"><p><b>CONTACT:</b><br />Pamela A. Mayer<br /><a href="https://api.newsfilecorp.com/redirect/ppVyoi3B1v">KAPLAN FOX &#38; KILSHEIMER LLP</a><br />800 Third Avenue, 38th Floor<br />New York, New York 10022<br />(646) 315-9003<br /><a href="mailto:pmayer@kaplanfox.com">pmayer@kaplanfox.com</a></p><p>Laurence D. King<br /><a href="https://api.newsfilecorp.com/redirect/YEjQ5ixBwV">KAPLAN FOX &#38; KILSHEIMER LLP</a><br />1999 Harrison Street, Suite 1501<br />Oakland, California 94612<br />(415) 772-4704<br /><a href="mailto:lking@kaplanfox.com">lking@kaplanfox.com</a></p></div><p>Contacting or submitting information to Kaplan Fox &#38; Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.</p><p><a href="https://api.newsfilecorp.com/redirect/0pAM1i5ZOz">https://www.kaplanfox.com/case/alignment-healthcare-investigation-learn-more/</a></p><p id="corporateNewsLogoContainer"><img src="https://images.newsfilecorp.com/files/12532/306289_63033b5c6489a84b_logo.jpg" id="corporateNewsLogo" alt="Corporate Logo" /></p><p id="corporateLinkBack">To view the source version of this press release, please visit <a href="https://api.newsfilecorp.com/redirect/RYN8wSwjE7">https://www.newsfilecorp.com/release/306289</a></p><p><img src="https://api.newsfilecorp.com/newsinfo/306289/197" alt="" /></p>

ALHC

Kaplan Fox Urges Investors of Alignment Healthcare, Inc. (ALHC) to Contact the Firm Regarding Potential Securities Law Violations

ALHC Under Scrutiny as Whistleblower Allegations Prompt Securities Investigation

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>New York, New York--(Newsfile Corp. - July 23, 2026) - Kaplan Fox &amp;amp; Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (&amp;#34;Alignment Healthcare&amp;#34; or the</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>A former Alignment Healthcare executive&#039;s whistleblower complaint accuses accounting irregularities that inflated EBITDA and misclassified expenses as capital expenditures. Kaplan Fox &amp; Kilsheimer LLP has launched a securities investigation, contributing to a 16.7% price drop to $20.03 on July 8, 2026. The development increases restatement and legal risk around ALHC&#039;s financials, pressuring valuation until clarity emerges.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Whistleblower alleges accounting irregularities at Alignment Healthcare inflating EBITDA.</li><li>Former exec claims misclassification of expenses as capex; lawsuit details reported July 8.</li><li>Alignment&#039;s stock fell 16.7% to $20.03 after the news.</li><li>Kaplan Fox solicits investor info; no attorney-client relationship.</li><li>No guarantee the investigation yields material impact or a restatement.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Alignment Healthcare, Inc. (ALHC)</strong>: Subject of the investigation; potential restatement risk and investor sentiment impact.</li><li><strong>Kaplan Fox &amp; Kilsheimer LLP (N/A)</strong>: Plaintiffs&#039; securities litigation firm issuing investor solicitations; signals potential litigation activity.</li><li><strong>Bank of America Corp. (BAC)</strong>: Historical high-value securities settlements cited by firm; context for potential litigation magnitudes.</li></ul>
  </section>

  <section data-block="category">
    <h3>Legal</h3>
    <p>Category: Legal; the piece centers on a securities investigation involving ALHC and related litigation risk, a legal risk signal for investors.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>ALHC closed at $20.03 on July 8, 2026, down 16.7%.</li><li>Investors face heightened regulatory and restatement risk amid the allegations.</li><li>Kaplan Fox&#039;s solicitation indicates potential litigation momentum, not guaranteed outcomes.</li><li>Stock could remain volatile until clarity on materiality and legal exposure.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>July 8, 2026: ALHC closed at $20.03, down 16.7%.</li><li>Whistleblower alleges accounting irregularities inflating EBITDA.</li><li>Misclassification of operating expenses as capital expenditures cited.</li><li>Kaplan Fox launched investor solicitation regarding Alignment investigation.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Near-term risk remains elevated; ALHC may remain volatile until clarity on the investigation and potential restatement emerges.</p>
  </section>
</section>


<p>New York, New York--(Newsfile Corp. - July 23, 2026) - <a href="https://api.newsfilecorp.com/redirect/Pq0WwHqzvb">Kaplan Fox &#38; Kilsheimer LLP</a> is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/ALHC">ALHC</a>).</p><p style="text-align: center;"><a href="https://api.newsfilecorp.com/redirect/wEQM1irgzV">CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION</a></p><p><b>If you are an Alignment Healthcare investor and have suffered losses, or if you have information that could assist in the Alignment Healthcare investigation, you may </b><a href="https://api.newsfilecorp.com/redirect/gJgVPHN1rD"><b>CLICK HERE</b></a><b> to contact us. You may also contact Kaplan Fox by emailing </b><a href="mailto:pmayer@kaplanfox.com"><b>pmayer@kaplanfox.com</b></a><b> or by calling (646) 315-9003.</b></p><p>On July 8, 2026, news emerged that a former Alignment Healthcare executive had filed a whistleblower complaint alleging the Company engaged in "accounting irregularities" that "artificially inflated" Alignment Healthcare's previously reported and projected financial results, including "Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization ("Adjusted EBITDA"), a key non-GAAP financial metric central to the Company's reported financial performance and executive compensation structure." According to the lawsuit "millions of dollars in operating expenses had been systematically misclassified as capital expenditures."  </p><p>Following this news, on July 8, 2026, the price of Alignment Healthcare stock fell $4.02 per share, or 16.7%, to close at $20.03 per share.</p><p><b>WHY CONTACT KAPLAN FOX?</b></p><p>Kaplan Fox &#38; Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.</p><p>Kaplan Fox is widely regarded as one of the nation's premier plaintiffs' securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in <i>In re Bank of America</i><span style="font-size: 12pt;">&#8212;</span>the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act<span style="font-size: 12pt;">&#8212;</span>$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in <i>ATRS v. Allianz Global Investors</i>, and a $475 million settlement in <i>In re Merrill Lynch</i>.</p><p>For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.</p><p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Past results do not guarantee future outcomes.</p><p>If you have any questions about this investigation, please contact:</p><div id="contactInfo"><p><b>CONTACT:</b><br />Pamela A. Mayer<br /><a href="https://api.newsfilecorp.com/redirect/ppVyoi3B1v">KAPLAN FOX &#38; KILSHEIMER LLP</a><br />800 Third Avenue, 38th Floor<br />New York, New York 10022<br />(646) 315-9003<br /><a href="mailto:pmayer@kaplanfox.com">pmayer@kaplanfox.com</a></p><p>Laurence D. King<br /><a href="https://api.newsfilecorp.com/redirect/YEjQ5ixBwV">KAPLAN FOX &#38; KILSHEIMER LLP</a><br />1999 Harrison Street, Suite 1501<br />Oakland, California 94612<br />(415) 772-4704<br /><a href="mailto:lking@kaplanfox.com">lking@kaplanfox.com</a></p></div><p>Contacting or submitting information to Kaplan Fox &#38; Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.</p><p><a href="https://api.newsfilecorp.com/redirect/0pAM1i5ZOz">https://www.kaplanfox.com/case/alignment-healthcare-investigation-learn-more/</a></p><p id="corporateNewsLogoContainer"><img src="https://images.newsfilecorp.com/files/12532/306289_63033b5c6489a84b_logo.jpg" id="corporateNewsLogo" alt="Corporate Logo" /></p><p id="corporateLinkBack">To view the source version of this press release, please visit <a href="https://api.newsfilecorp.com/redirect/RYN8wSwjE7">https://www.newsfilecorp.com/release/306289</a></p><p><img src="https://api.newsfilecorp.com/newsinfo/306289/197" alt="" /></p>

A former Alignment Healthcare executive's whistleblower complaint accuses accounting irregularities that inflated EBITDA and misclassified expenses as capital expenditures. Kaplan Fox & Kilsheimer LLP has launched a securities investigation, contributing to a 16.7% price drop to $20.03 on July 8, 2026. The development increases restatement and legal risk around ALHC's financials, pressuring valuation until clarity emerges.

News insight

Kaplan Fox Urges Investors of Alignment Healthcare, Inc. (ALHC) to Contact the Firm Regarding Potential Securities Law Violations

AI summary

Sentiment rationale

Key facts

Legal